Cyclin dependent kinase inhibitors

Cancer Surveys

Volumn 29, Issue , 1997, Pages 91-107

  Wade Harper, J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P27;

ANIMAL CELL; ANIMAL TISSUE; CANCER INHIBITION; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; ENZYME INHIBITION; MITOGENESIS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL CYCLE; CELL SURVIVAL; CYCLIN-DEPENDENT KINASES; MICE; MICE, KNOCKOUT; MUTAGENESIS; NEOPLASMS; PHOSPHORYLATION;

EID: 1842374435     PISSN: 02612429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. Bates S and Vousden KH (1996) p53 in signaling checkpoint arrest or apoptosis. Current Opinions in Genetics and Development 6 12-18
2. Bates S, Parry D, Bonetta K, Vousden K, Dickson C and Peters G (1994) Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene 9 1633-1640
3. Brugarolas J, Chandrasekaran C, Gordon J et al (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377 552-556
4. Chan FKM, Zhang J, Cheng L, Shapiro D and Winoto A (1995) Identification of human and mouse p19, a novel Cdk4 and Cdk6 inhibitor with homology to p16ink4. Molecular and Cellular Biololgy 15 2682-2688
5. Coats S, Flanagan W M, Nourse J and Roberts J M (1996) Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272 877-880
6. Coleman TR and Dunphy WG (1994) Cdc2 regulatory factors. Current Opinions in Cell Biology 6 877-882
7. 1 checkpoint control. Cell 82 675-684
8. 1arrest. Cell 76 1013-1023
9. El-Deiry WS, Tokino T, Velculescu VE et al (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 78 67-74
10. 1 arrest and apoptosis. Cancer Research 54 1169-1174
11. El-Deiry WS, Tokino T, Waldman T et al (1995) Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Research 55 2910-2919
12. Elledge S J and Harper J W (1994) Cdk inhibitors on the threshold of checkpoints and development. Current Opinions in Cell Biology 6 847-852
13. Fahraeus R, Paramio JM, Ball KL, Lain S and Lane DP (1996) Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A. Current Biology 6 84-91
14. Fero ML, Rivkin M, Tasch M et al (1996) A syndrome of multi-organ hyperplasia with features of gigantism, tumorigenesis and female sterility in p27KIP1 deficient mice. Cell 85 733-744
15. Firpo EJ, Koff A, Solomon M and Roberts JM (1994) Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Molecular and Cellular Biology 14 4889-4901
16. Flores-Rozas H, Kelman Z, Dean F et al (1994) Cdk-interacting protein 1 directly binds with PCNA and inhibits replication catalyzed by the DNA polymerase δ holoenzyme. Proceedings of the National Acadamy of Sciences of the USA 91 8655-8659
17. Gao X, Chen YQ, Wu N et al (1995) Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer Oncogene 11 1395-1898
18. Goubin F and Ducommun B (1995) Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor. Oncogene 10 2281-2287
19. Gruis N, van der Velden PA, Sandkuijl A et al (1995) Homozygotes for CDKN2(pl6) germline mutation in Dutch familial melanoma kindreds. Nature Genetics 10 351-353
20. Guan K-L, Jenkins CW, Li Y et al (1994) Growth suppression by p18, a p16 and p14-related Cdk6 inhibitor, correlates with wild-type pRb function. Genes and Development 8 2939-2952
21. Halevy O, Novitch B, Spicer D et al (1995) Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267 1018-1021
22. Hall M, Bates S and Peters G (1995) Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 11 1581-1588
23. Hannon G and Beach D (1994) p15 is a potential effector of TGFβ-induced cell cycle arrest. Nature 370 257-261
24. Harlow E (1992) Retinoblastoma: for our eyes only. Nature 359 270-271
25. Harper JW and Elledge SJ (1996) Cdk inhibitors in development and cancer. Current Opinions in Genetics and Development 6 56-64
26. 1 cyclin-dependent kinases. Cell 75 805-816
27. Harper JW, Elledge SJ, Keyomarsi K et al (1995) Inhibition of cyclin dependent kinases by p21. Molecular Biology of the Cell 6 387-400
28. Hatada I and Mukai T (1995) Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nature Genetics 11 204-206
29. Hengst L and Reed SI (1996) Translational control of p27Kipl accumulation during the cell cycle. Science 271 1861-1864
30. Herman JG, Merlo A, Mao L et al (1995) Inactivation of the CDKN2/pl6/MTS1 gene is fre- quently associated with aberrant DNA methylation in all common human cancers. Cancer Research 55 4525-4530
31. Hermeking H, Funk JO, Reichert M, Eilwart JW and Eick D (1995) Abrogation of p53-induced cell cycle arrest by c-Myc: evidence for an inhibitor of p21WAF1/CIP1/SDI1. Oncogene 11 1409-1415
32. Hirai H, Roussel MF, Kato JY, Ashmun RA and Sherr C (1995) Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin dependent kinases Cdk4 and Cdk6. Molecular and Cellular Biology 15 2672-2681
33. Hirama T and Koeffler H P (1995) Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86 841-854
34. Hunter T and Pines J (1994) Cyclins and Cancer: II. Cell 79 573-582
35. Hussussian CJ, Struewing JP, Goldstein AM et al (1994) Germline p16 mutations in familial melanoma. Nature Genetics 8 15-21
36. Jen J, Harper JW, Bigner SH et al (1994) Deletion of p16 and p15 genes in brain tumors. Cancer Research 54 6353-6358
37. Jiang H, Lin J, Su Z-Z et al (1994) Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21WAF1/CIP1 expression in the absence of p53. Oncogene 9 3397-3406
38. Kamb A, Shattuck-Eidens D, Eeles R et al (1994) Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genetics 8 22-26
39. Kiyokawa H, Kineman RD, Manova-Todorova KO et al (1996) Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27Kip1. Cell 85 721-732
40. Koh J, Enders GH, Dynlacht BD and Harlow E (1995) Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375 506-510
41. Kondo M, Matsuoka S, Uchida K et al (1996) Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11 p15.5. Oncogene 12 1365-1368
42. Lee M-H, Reynisdottir I and Massague J (1995) Cloning of p57Kip2, a cyclin-dependent kinase inhibitor with a unique domain structure and tissue distribution. Genes and Development 9 650-662
43. Li R, Waga S, Hannon GJ, Beach D and Stillman B (1994) Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371 534-537
44. Liu M, Lee M H, Cohen M, Bommakanti M and Freedman L P (1996) Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes and Development 10 142-153
45. Lukas J, Parry D, Aagard L et al (1995) Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375 503-506
46. Luo Y, Hurwitz J and Massague J (1995) Cell cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 375 159-161
47. Mal A, Poon RYC, Howe PH, Toyoshime H, Hunter T and Harter ML (1996) Inactivation of p27Kipl by the viral E1A oncoprotein in TGFβ-treated cells. Nature 380 262-265
48. Matsuoka S, Edwards M, Bai C et al (1995) p57KIP2, a structurally distinct member of the p21Cip1 Cdk inhibitor family is a candidate tumor suppressor protein. Genes and Development 9 650-662
49. Matsuoka S, Thompson JS, Edwards MC et al (1996) Variable imprinting of a human cyclin-dependent kinase inhibitor, p57KIP2. Preceedings of the National Academy of Sciences of the USA 93 3026-3030
50. Morgan D (1995) Principles of Cdk regulation. Nature 374 131-134
51. Nakayama K, Ishida N, Shrane M et al (1996) Mice lacking p27 (Kipl) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85 707-720
52. Nourse J, Firpo E, Flanagan WM et al (1994) Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372 570-573
53. Pagano M, Tan SW, Theodoras AM et al (1995) Role of the ubiquitin-proteosome pathway in regulating the abundance of the cyclin dependent kinase inhibitor p27. Science 269 682- 685
54. Pan ZQ, Reardon J and Li L (1995) Inhibition of nucleotide excision repair by the cyclindependent kinase inhibitor p21. Journal of Biological Chemistry 270 22008-22016
55. Parker S, Eichele G, Zhang P et al (1995) p53-inpedentdent expression of p21Cip1 in muscle and other terminally differentiated cells. Science 267 1024-1027
56. Parry D and Peters G (1996) Temperature-sensitive mutants of p16CDKN2 associated with familial melanoma. Molecular and Cellular Biology 16 3844-3852
57. Parry D, Bates S, Mann DJ and Peters G (1995) Lack of cyclin D/cdk4 complexes in Rbnegative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO Journal 14 503-511
58. Polyak K, Lee MH, Erdjument-Bromage H, Tempst P and Massague J (1994) Cloning of p27KIP1, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals. Cell 78 59-66
59. Poon RYC, Toyoshima H and Hunter T (1995) Redistribution of the CDK inhibitor p27 between different cyclin-Cdk complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Molecular Biology of the Cell 6 1197-1213
60. Quelle D, Zindy F, Ashmun R and Sherr C (1995) Alternative reading frames of the INK4a tumor suppressor gene encodes two unrelated proteins capable of inducing cell cycle arrest. Cell 83 993-1000
61. 1 to S transition in S. cerevisiae. Cell 79 233-244
62. Serrano M, Hannon GJ and Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366 704-707
63. Serrano M, Lee H-W, Chin L, Cordon-Gardo C, Beach D and DePihno R (1996) Role of the INK4a locus in tumor suppression and cell mortality. Cell 85 27-37
64. 1 phase progression: cycling on cue. Cell 79 551-555
65. Sherr CJ and Roberts JM (1995) Mammalian cyclin-dependent kinase inhibitors. Genes and Development 91 149-1163
66. Shiohara M, El-Deiry WS, Wada M et al (1994) Absence of WAF1 mutations in a variety of human malignancies. Blood 84 3781-3784
67. Shivji MKK, Grey SJ, Strausfeld UP, Wood RD and Blow J (1994) Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision-repair. Current Biology 4 1062-1068
68. Shou W and Dunphy WG (1996) Cell cycle control by Xenopus p28Kixl, a developmentally regulated inhibitor of cyclin-dependent kinases. Molecular Biology of the Cell 7 457-469
69. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann CA and El-Houseini ME (1994) Induction of p21(WAF1/GIP1) during differentiation. Oncogene 9 3389-3396
70. Su J-Y, Rempel RE, Erikson E and Maller JL (1995) Cloning and characterization of the Xenopus cyclin-dependent kinase inhibitor p27Xicl. Proceeding of the National Academy of Sciences of the USA 92 10187-10191
71. Tam SW, Shay JW and Pagano M (1994) Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4. Cancer Research 54 5816-5820
72. 1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78 67-74
73. Waga S, Hannon G, Beach D and Stillman B (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369 574-578
74. Walker GJ, Hussussian CJ, Flores JF et al (1995) Mutations of the CDKN2/pl6INK4 gene in Australian melanoma kindreds. Human Molecular Genetics 4 1845-1852
75. Warbrick E, Lane D, Glover DM and Cox LS (1995) A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen. Current Biology 5 275-282
76. Weinberg RA (1995) The retinoblastoma protein in cell cycle control. Cell 81 323-330
77. Williams BO and Jacks T (1996) Mechanisms of carcinogenesis and the mutant mouse. Current Opinions in Genetics and Development 6 65-70
78. 1 cyclins and the Cdk inhibitor p27Kip1 by platelet-derived growth factor and plasma factors in density arrested fibroblasts.Journal of Biological Chemistry 271 11253-11260
79. Wolfel T, Hauer M, Schneider J et al (1995) A p16Ink4a-insensitive CDK4 mutant targeted by cytotoxic T lymphocutes in a human melanoma. Science 269 1281-1284
80. Xiong Y, Hannon G, Zhang H, Casso D, Kobayashi R and Beach D (1993a) p21 is a universal inhibitor of cyclin kinases. Nature 366 701-704
81. Xiong Y, Zhang H and Beach D (1993b) Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes and Development 7 1572-1583
82. Zhang H, Hannon G and Beach D (1994) p21-containing cyclin kinases exist in both active and inactive forms. Genes and Development 8 1750-1758
83. Zhu L, Harlow E and Dynlacht B (1995) p107 uses a p21CIP1 related domain to bind cyclin/Cdk2 and regulate interacts with E2F. Genes and Development 9 1740-1752
84. Zuo L, Weger J, Yang Q et al (1996) Germline mutations in the p16INK4a binding domain of Cdk4 in familial melanoma. Nature Genetics 12 97-99